HLA-Matched Related Donor Hematopoietic Cell Transplantation in 43 Patients with Fanconi Anemia Conditioned with 60 mg/kg of Cyclophosphamide

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 12, 2007, Pages 1455-1460

  Bonfim, Carmem M ^a   de Medeiros, Carlos R ^a   Bitencourt, Marco A ^a   Zanis Neto, José ^a   Funke, Vaneuza A M ^a   Setubal, Daniela C ^a   Ruiz, Jefferson ^a   Sanders, Jean E ^b   Flowers, Mary E D ^b   Kiem, Hans Peter ^b   Storb, Rainer ^b   Pasquini, Ricardo ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Fanconi anemia; HLA matched marrow graft; Low dose cyclophosphamide

Indexed keywords

ACICLOVIR; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUCONAZOLE; FLUDARABINE; GANCICLOVIR; MESNA; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DONOR; FANCONI ANEMIA; FATALITY; FEMALE; GASTROINTESTINAL TOXICITY; GRAFT FAILURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HERPES SIMPLEX; HLA MATCHING; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LIVER FAILURE; MALE; MUCOSA INFLAMMATION; MYCOSIS; PNEUMOCYSTIS PNEUMONIA; RELATIVE; RETREATMENT; SEIZURE; SIBLING; SURVIVAL TIME; TREATMENT RESPONSE; VIRUS REACTIVATION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DIRECTED TISSUE DONATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FANCONI ANEMIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; MALE; MYELOABLATIVE AGONISTS; SURVIVAL ANALYSIS; SURVIVORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 36048955162     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.08.004     Document Type: Article

References (27)

1. Young N.S., and Alter B.P. Clinical features of Fanconi's anemia. Aplastic Anemia, Acquired and Inherited (1994), W.B. Saunders Co, Philadelphia 275-309
2. Gluckman E., Auerbach A.D., Horowitz M.M., et al. Bone marrow transplantation for Fanconi anemia. Blood 86 (1995) 2856-2862
3. Flowers M.E.D., Zanis J., Pasquini R., et al. Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation. Br J Haematol 92 (1996) 699-706
4. Zanis-Neto J., Ribeiro R.C., Medeiros C., et al. Bone marrow transplantation for patients with Fanconi anemia: a study of 24 cases from a single institution. Bone Marrow Transplant 15 (1995) 293-298
5. Medeiros C., Zanis-Neto J., and Pasquini R. Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning. Bone Marrow Transplant 24 (1999) 849-852
6. Zanis-Neto J., Flowers M.E.D., Medeiros C.R., et al. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anemia. Br J Haematol 130 (2005) 99-106
7. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18 (1974) 295-304
8. Lee S.J., Vogelsang G., and Flowers M.E.D. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9 (2003) 215-233
9. Santos G.W., and Owens Jr. A.H. Allogeneic marrow transplants in cyclophosphamide treated mice. Transplant Proc 1 (1969) 44-46
10. Storb R., Epstein R.B., Rudolph R.H., and Thomas E.D. Allogeneic canine bone marrow transplantation following cyclophosphamide. Transplantation 7 (1969) 378-386
11. Storb R., Buckner C.D., Dillingham L.A., and Thomas E.D. Cyclophosphamide regimens in rhesus monkeys with and without marrow infusion. Cancer Res 30 (1970) 2195-2203
12. Deeg H.J., Storb R., Prentice R., et al. Increased cancer risk in canine radiation chimeras. Blood 55 (1980) 233-239
13. Witherspoon R.P., Storb R., Pepe M., Longton G., and Sullivan K.M. Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone. Blood 79 (1992) 289-292 (Letter)
14. Deeg H.J., Socié G., Schoch G., et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 87 (1996) 386-392
15. Storb R., Thomas E.D., Buckner C.D., et al. Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43 (1974) 157-180
16. Gluckman E., Devergie A., Schaison G., et al. Bone marrow transplantation for Fanconi anaemia. Br J Haematol 45 (1980) 557-564
17. Deeg H.J., Storb R., Thomas E.D., et al. Fanconi's anemia treated by allogeneic marrow transplantation. Blood 61 (1983) 954-959
18. Storb R., Prentice R.L., and Thomas E.D. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 296 (1977) 61-66
19. Farzin A., Davies S.M., Smith F.O., et al. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience. Br J Haematol 136 (2007) 633-640
20. Bitan M., Or R., Shapira M.Y., et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant 12 (2006) 712-718
21. Wagner J.E., Eapen M., MacMillan M.L., et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 109 (2007) 2256-2262
22. Guardiola P., Socie G., Li X., et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood 103 (2004) 73-77
23. Ayas M., Al-Jefri A., Al-Mahr M., et al. Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophospha-mide and antithymocyte globulins withour the use of radiation therapy. Bone Marrow Transplant 35 (2005) 463-466
24. Rosenberg P.S., Alter B.P., Socie G., and Gluckman E. Secular trends in outcomes for Fanconi anemia patients who receive transplants: implications for future studies. Biol Blood Marrow Transplant 11 (2005) 672-679
25. Nash R.A., Pepe M.S., Storb R., et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 80 (1992) 1838-1845
26. Storb R., Prentice R.L., Sullivan K.M., et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 98 (1983) 461-466
27. Rosenberg P.S., Socie G., Alter B.P., and Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 105 (2005) 67-73